Pfizer to get patent for cholesterol lowering formulation
Global pharma giant Pfizer Inc has received a patent for invention to address the issues related to cholesterol and related disease including cardiovascular disease. The Indian Patent Office has said that the company amended its set of claims for ... Conference Call
Pfizer Ltd has submitted to BSE a copy of the transcript of the tele conference call with the analysts held on February 04, 2016, to discuss the Company's financial performance for the quarter ended December 31, 2015.The aforesaid information will be displayed on the website of the Company in compliance with Regulation 46 of the Listing Regulations. Updates
Pfizer Ltd has informed BSE that a teleconference call has been scheduled with the analysts on Thursday, February 04, 2016, at 3.30 p.m. to discuss the Company's financial performance for the quarter ended December 31, 2015. Results Press Release
Pfizer Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2015. Announces Q3 Results (Standalone) & Limited Review Report (Standalone) for the Quarter ended December 31, 2015
Pfizer Ltd has announced the following Un-Audited Standalone results for the quarter ended December 31, 2015 :The Company has posted a net profit of Rs. 403.40 million for the quarter ended December 31, 2015 as compared to Rs. 183.70 million for the quarter ended December 31, 2014. Total Income has increased from Rs. 4914.10 million for the quarter ended December 31, 2014 to Rs. 5300.10 million for the quarter ended December 31, 2015. Pfizer forecasts 2016 revenue, earnings below estimates
Company's net income fell to $613 million, or 10 cents per share in the fourth quarter Shareholding for the Period Ended December 31, 2015
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Q3 results on Feb 03, 2016
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 03, 2016, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2015 (Q3).Further, the Trading Window for trading in the Equity shares of the Company will be closed from January 22, 2016 to February 05, 2016, both days inclusive. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Pfizer Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pfizer said to weigh sale of pump unit acquired in Hospira deal
Pfizer could fetch about $2 billion from a potential sale, according to sources